B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ipatasertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ipatasertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

a
3 shared targets
mk
3 shared targets
borussertib
3 shared targets
gsk
3 shared targets
afuresertib
3 shared targets
capivasertib
4 shared targets
uprosertib
3 shared targets
gsk
4 shared targets
hydroxyfasudil
2 shared targets · score 27.5
enzastaurin
2 shared targets
Loading evidence profile...

This evidence profile for Ipatasertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.